Cargando…

Porous 3D Prussian blue/cellulose aerogel as a decorporation agent for removal of ingested cesium from the gastrointestinal tract

In the present study, we successfully synthesized a porous three-dimensional Prussian blue-cellulose aerogel (PB-CA) composite and used it as a decorporation agent for the selective removal of ingested cesium ions (Cs(+)) from the gastrointestinal (GI) tract. The safety of the PB-CA composite was ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ilsong, Kim, Sung-Hyun, Rethinasabapathy, Muruganantham, Haldorai, Yuvaraj, Lee, Go-Woon, Choe, Sang Rak, Jang, Sung-Chan, Kang, Sung-Min, Han, Young-Kyu, Roh, Changhyun, Cho, Wan-Seob, Huh, Yun Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851989/
https://www.ncbi.nlm.nih.gov/pubmed/29540724
http://dx.doi.org/10.1038/s41598-018-22715-w
Descripción
Sumario:In the present study, we successfully synthesized a porous three-dimensional Prussian blue-cellulose aerogel (PB-CA) composite and used it as a decorporation agent for the selective removal of ingested cesium ions (Cs(+)) from the gastrointestinal (GI) tract. The safety of the PB-CA composite was evaluated through an in vitro cytotoxicity study using macrophage-like THP-1 cells and Caco-2 intestinal epithelial cells. The results revealed that the PB-CA composite was not cytotoxic. An adsorption study to examine the efficiency of the decorporation agent was conducted using a simulated intestinal fluid (SIF). The adsorption isotherm was fitted to the Langmuir model with a maximum Cs(+) adsorption capacity of 13.70 mg/g in SIF that followed pseudo-second-order kinetics. The PB-CA composite showed excellent stability in SIF with a maximum Cs(+) removal efficiency of 99.43%. The promising safety toxicology profile, remarkable Cs(+) adsorption efficacy, and excellent stability of the composite demonstrated its great potential for use as an orally administered drug for the decorporation of Cs(+) from the GI tract.